New Hope for Detecting Early Stage Pulmonary Hypertension

Data from collaborative study between MiRXES and Janssen demonstrate how miRNA-based biomarker signatures could lead to potential in early identification and diagnosis of pulmonary hypertension.

Artificial Intelligence Tool to Predict Severity of Pneumonia

New predictive engine powered by artificial intelligence developed by Changi General Hospital (CGH) and the Integrated Health Information System (IHiS) to determine severity of pneumonia in patients.

Leveraging on Blockchain Technology for Personal COVID-19 Medical Records

SGInnovate and Accredify co-develop the Digital Health Passport to store verified medical documents for individuals as a digital wallet.

Novotech and PPC Group Merge to form Largest Specialist Biotech CRO Platform

Newly formed Novotech Health Holdings will serve Asia to meet the rapidly growing demand for quality clinical trial services in the region.

Singapore Company Homage Launches Teleconsultation and Mobile Medicine Programme

Telemedicine has become especially important in the face of COVID-19. Homage Health, a new programme launched by Singaporean company Homage, provides teleconsultation services supplemented by in-person support to provide holistic healthcare services.

Advanced Therapy Manufacturing and Innovation (ATMI) Grant 2020 Launched by Terumo Blood and Cell Technologies

In September, Terumo Blood and Cell Technologies announced the Advanced Therapy Manufacturing and Innovation (ATMI) Grant 2020 for the Asia-Pacific region, with the goal of supporting novel research using the company’s Quantum® Cell Expansion System.

Patent Granted for Automated Heart Ultrasound Analysis Workflow

Formerly known as eko.ai, the newly rebranded Us2.ai has gained patent licencing for its automated clinical workflow for heart ultrasound analysis. Working in collaboration with Janssen and AstraZeneca, to automate the fight against cardiovascular disease.

New Research Methodology for identifying SARS-CoV-2

Genesis Healthcare Co. reveals research methodology for identification and reduction of SARS-CoV-2 false negative for RT-PCT tests.

MedTech Start-up Granted FDA Clearance for Artificial Intelligence Software

See-Mode Technologies announced in early October 2020 that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its debut product, Augmented Vascular Analysis (AVA).